Michael Clemens

12.2k citations
122 papers · 5.4k · 4 hit papers · h-index 32

Impact in

  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Pancreatic and Hepatic Oncology Research
    • Bone health and treatments
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 16
    • Pancreatic and Hepatic Oncology Research 15
    • HER2/EGFR in Cancer Research 14
    • Colorectal Cancer Treatments and Studies 11
    • Advanced Breast Cancer Therapies 12
    • Gastric Cancer Management and Outcomes 8

Michael Clemens

116 papers receiving 5.1k citations

Michael Clemens's Hit Papers

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials 2012 · 446 citations
4460+6+13Years since publication200400600

Peers

Michael Clemens
Comparison fields: 5 of 116
  • Oncology 2.9k
  • Cancer Research 785
  • Pulmonary and Respiratory Medicine 1.1k
  • Biochemistry 197
  • Radiology, Nuclear Medicine and Imaging 599
Replace Jiuwei Cui with:
Jiuwei Cui China
Samuel Waxman United States
Raymond J. Hohl United States
Marco M. Gottardis United States
Winston Tan United States
Hiroaki Ohigashi Japan
Eran Leitersdorf Israel
Takuma Nemoto United States
Sumio Kawata Japan
Floriana Morgillo Italy
Michael Clemens relative to Jiuwei Cui China Jiuwei Cui's profile →
Citations per field
00.5×3.4×
Jiuwei Cui · 1×
Citations per year

Countries citing papers authored by Michael Clemens

Since Specialization
Citations

This map shows the geographic impact of Michael Clemens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Clemens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Clemens more than expected).

Fields of papers citing papers by Michael Clemens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Clemens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Clemens. The network helps show where Michael Clemens may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Clemens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Clemens Line = papers co-authored together Michael Clemens links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
Hit paper breakdown →
2009634
2
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
Hit paper breakdown →
2006552
3
Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
Hit paper breakdown →
2009520
4
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Hit paper breakdown →
2012446
5 2005329
6 1987295
7 2008186
8 2000150
9 2008132
10 1996105
11 2000104
12 1985101
13 201489
14 200380
15 201978
16 201277
17 201470
18 199870
19 199064
20 199163

About Michael Clemens

Michael Clemens is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 122 papers that have together received 5.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer Treatment and Pharmacology (16 papers), Pancreatic and Hepatic Oncology Research (15 papers), HER2/EGFR in Cancer Research (14 papers), Advanced Breast Cancer Therapies (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Genomics and Diagnostics (9 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Oncology (2.9k citations), Cancer Research (785 citations), Pulmonary and Respiratory Medicine (1.1k citations), Biochemistry (197 citations) and Radiology, Nuclear Medicine and Imaging (599 citations). Michael Clemens has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans Dierck Waller, Hermann Einsele, H. Remmer, Bella Kaufman, Volker Heinemann, Michaela K. Jahn, Ashok K. Vaid, Alison Jones, Sergei Tjulandin and P. P. Bapsy. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Cancer Research and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact